Updated Perinatal Treatment Guidelines Released!
AIDSinfo is proud to announce that the latest update to the Public Health Service Task Force Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States has been released. The new version includes:
- A new brief discussion of recent trials on the use of antiretroviral drugs for prevention of mother-to-child HIV transmission through breastfeeding
- A more detailed discussion of duration of infant zidovudine prophylaxis
- Updated information regarding carcinogenicity and teratogenicity studies in animals
- Information on the new drug etravirine
- An updated Safety and Toxicity supplement
Changes are highlighted in yellow throughout the text and tables.
In addition to the updated content, this revision was developed using a new format in which the relevant tables and references for each section are incorporated into the body of the document. A separate PDF file including all the tables can be found at the AIDSinfo Web site.
The updated guidelines are available for download from the Perinatal Guidelines section of the AIDSinfo Web site. You can also request to receive them by e-mail from the AIDSinfo Order Publications section.
Your Feedback Is Important!
The HHS Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission would like to hear your feedback on the latest revisions to the Public Health Service Task Force Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States. Please send your comments with the subject line "Perinatal Comments" to AIDSinfoWebmaster@aidsinfo.nih.gov by May 13, 2009.
